International Patent: DOUBLE-ORIFICE MITRAL VALVE REPLACEMENT IMPLANT

GENEVA, July 6 -- SHANGHAI CINGULAR BIOTECH CORPORATION filed a patent application (CN2025/101580) for “DOUBLE-ORIFICE MITRAL VALVE REPLACEMENT IMPLANT”. With publication no. WO/2026/137725, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61F 2/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....